| Předmět: |
|
| Zdroj: |
Vaccine Weekly; 6/15/2024, p1045-1045, 1p |
| Abstrakt: |
A recent study conducted by researchers at the University of Maryland focuses on the structure and diversity of the Hepatitis C Virus (HCV) and its implications for vaccine development. HCV is a significant global health burden and the leading cause of chronic liver disease and cancer. The study highlights the challenges in developing an effective HCV vaccine due to the virus's high variability and ability to escape the immune response. The researchers propose a rational design approach using the E1E2 envelope glycoprotein and a multivalent nanoparticle-based vaccine to address viral diversity and escape. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
